CoChat

Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder?

Open access

The DOI matches its Crossref record; 58 of the 62 references it cites were found in a registry or an index, and 2 are not checked yet; 3 of the 22 sources its claims cite were checked for support.

Abstract

Background: To explore the relationship between serum levels of inflammatory markers and symptomatic severity of bipolar disorder (BD). Materials and methods: A cross-sectional study was conducted on 126 BD patients with current depressive episode (BDD), 102 BD patients with current mixed or (hypo)manic episode (BDM) and 94 healthy controls (HC). All participants were drug-naïve and had no current active physical illness associated with inflammatory response or history of substance abuse. Fasting serum levels of CRP, leptin (LEP), adiponectin (ADP), visfatin (VIS), TNF-α, IL-2, IL-6, IL-10, IL-17), and monocyte chemoattractant protein-1 (MCP-1) were measured with enzyme-linked immunosorbent assay (ELISA). Symptomatic severity of BD was assessed with HAMD-17 and YMRS. Generalized linear model was used to determine the association between the serum levels of inflammatory markers and symptomatic severity of BD. Results: The serum levels of IL-6, IL-10 and IL-17, and the IL-6/IL-10 ratio were significantly lower in mild BDD than in HC. In moderate BDD, the serum levels of MCP, IL-6 and IL-17 were significantly lower than in HC. In severe BDD, the serum level of ADP, MCP-1, IL-10 and IL-17and the IL-17/IL-10 ratio were significantly lower than in HC. The serum levels of TNF-α and the IL-6/IL-10 ratio were significantly higher in mild BDM than in HC. In moderate BDM, the serum level of VIS, IL-2, and IL-17 were significantly higher than in HC, but the IL-6/IL-10 ratio was significantly lower than in control. In severe BDM, the serum levels of IL-6 and IL-17 and the ratios of IL-6/IL-10 and IL-17/IL-10 were significantly lower than in HC, but the neutrophil/lymphocyte ratio was significantly higher than in HC. Conclusion: In BDD, immune-inhibition is persistently predominant, while in mild-to-moderate BDM, immune system is activated but inhibited in severe BDM. The dynamic change of serum inflammatory markers suggests that alteration of peripheral inflammatory markers in BD is state-dependent instead of trait-marked.

Verified 2026-10-05 · 2 references not checked yet

Overview

CoChat Summary

TL;DR

In a cross-sectional study of 228 drug-naïve bipolar disorder (BD) patients and 94 healthy controls, serum inflammatory markers varied by episode type and symptom severity: bipolar depression showed persistent immune-inhibition, while (hypo)manic/mixed episodes showed activation in mild-to-moderate states and inhibition in severe states. The authors conclude that peripheral inflammatory alterations in BD are state-dependent rather than trait-marked.

Key findings

  • In bipolar depressive episode (BDD), most observed markers decreased versus healthy controls (HC): mild BDD had lower IL-6, IL-10, and IL-17; moderate BDD had lower MCP, IL-6, and IL-17; severe BDD had lower ADP, MCP-1, IL-10, and IL-17, plus a lower IL-17/IL-10 ratio.
  • In (hypo)manic/mixed episode (BDM), mild BDM had higher TNF-α and a lower IL-6/IL-10 ratio; moderate BDM had higher VIS, IL-2, and IL-17 but a lower IL-6/IL-10 ratio; severe BDM had lower IL-6, IL-17, IL-6/IL-10, and IL-17/IL-10, but a higher neutrophil/lymphocyte ratio.
  • The authors report that immune-inhibition is persistently predominant in BDD, whereas BDM shows immune activation in mild-to-moderate severity and inhibition in severe severity.

Methods

  • Cross-sectional study of 126 BD patients with current depressive episode, 102 BD patients with current mixed or (hypo)manic episode, and 94 healthy controls; participants were Han Chinese, aged 16–65, drug-naïve, without current active physical illness associated with inflammatory response, and without psychoactive substance abuse in the past six months.
  • Fasting serum levels of CRP, leptin, adiponectin, visfatin, TNF-α, IL-2, IL-6, IL-10, IL-17, and MCP-1 were measured by ELISA; symptomatic severity was assessed with HAMD-17 and YMRS.
  • Generalized linear models assessed associations between inflammatory markers and symptom severity, adjusting for age, gender, marital status, BMI, education, and severity of manic or depressive symptoms, with Bonferroni-adjusted significance testing.

Limitations

  • The paper states that the cross-sectional design limits causal conclusions; some potential confounders such as cognitive symptoms and atypical features were not assessed; the sample may still be too small to detect small but clinically meaningful effects, especially in subgroups; some inflammatory marker data were too dispersed to build a good generalized linear model; no patients in remission were enrolled; and only serum markers, not central nervous system markers, were measured.
  • Evident from the text: the sample was Han Chinese, recruited from one hospital and local community, and mostly young, which may limit generalizability to other populations or older patients.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2022.1063479

Cites

58 of 60 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

2 Valid · 0 Not valid · 9 Not checked · 60 Own results and interpretations

39 more claims

Create a free account to see all 71 claims and to verify the 19 references still open.

See all claims — free account
  • The quote only partly states this claim. 2
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 16

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 8 · the rest aren’t loaded

3 more findings

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 60 references

Cited by

See all 28

Metadata

Authors
Wu, X., Chen, Z., Liao, Y., Yang, Z., Liang, X., Guan, N., & Gan, Z.
Affiliations
Third Affiliated Hospital of Sun Yat-sen University (CN)
Corresponding author
  • Guan, Nianhong
  • Gan, Zhaoyu
Venue
Frontiers in Psychiatry
Published
2023-01-20
Volume
13
Pages
1063479-1063479
ISSN
1664-0640 (ISSN-L)
OpenAlex
W4317513111
Cited by
23
References
62
Citations by year
2026: 5 · 2025: 9 · 2024: 5 · 2023: 4
FWCI
4.66
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Natural Science Foundation of Guangdong Province
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
bipolar disorder, inflammatory markers, serum cytokines, symptom severity, depressive episodes, manic episodes, mixed states, interleukin-6, IL-10, IL-17, IL-6/IL-10 ratio, MCP-1, TNF-α, leptin, adiponectin, visfatin, neutrophil-to-lymphocyte ratio, immune activation, C-reactive protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder? https://app.cochat.ai/papers/10.3389/fpsyt.2022.1063479
The paper
Wu, X., Chen, Z., Liao, Y., Yang, Z., Liang, X., Guan, N., & Gan, Z. (2023). Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder? Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.1063479

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.